Kevin Dai

Managing Director at Vivo Capital

Kevin Dai, Pharm.D, BCOP, joined Vivo with healthcare and sell side equity research experience. Prior to Vivo, Kevin worked at Memorial Sloan Kettering Cancer Center for 3 years as a Clinical Oncology Pharmacy Specialist in the hematology department, where he provided direct patient care and managed all active clinical trials within the leukemia department. He then worked at Canaccord Genuity as an equity research associate covering small to large cap biotechnology and specialty pharmaceutical companies. Additionally, Kevin interned at Merck & Co. in the ion channel department, where his research has been published in multiple medical journals, including Biochemistry, PNAS, and Bone Marrow Transplantation.

Kevin received a Pharm.D from Ernest Mario School of Pharmacy at Rutgers. He then completed his internal medicine residency at University of Chicago Medical Center and his oncology residency at Memorial Sloan Kettering Cancer center. He is a board certified oncology pharmacist (BCOP).

Links

Timeline

  • Managing Director

    June, 2021 - present

  • Executive Director

View in org chart